Cyclo Therapeutics Announces Execution Of Definitive Agreement With Rafael Holdings For $5M Private Placement
Portfolio Pulse from Benzinga Newsdesk
Cyclo Therapeutics has executed a definitive agreement with Rafael Holdings for a $5 million private placement. This will provide additional funding for the company's ongoing operations.
June 05, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cyclo Therapeutics receives $5M in private placement from Rafael Holdings, providing additional funding for ongoing operations.
The $5M private placement from Rafael Holdings directly benefits Cyclo Therapeutics by providing additional funding for their ongoing operations. This is likely to have a positive impact on CYTH's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Rafael Holdings invests $5M in Cyclo Therapeutics through a private placement agreement.
Rafael Holdings' investment in Cyclo Therapeutics may not have a significant short-term impact on RFL's stock price, as it is a relatively small investment for the company. However, it does show their interest in expanding their portfolio.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100